Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 1265       

   Table of Contents      
EDITORIAL
Year : 2015  |  Volume : 141  |  Issue : 2  |  Page : 143-144

International Epilepsy Day - A day notified for global public education & awareness


1 Department of Neurology, Janakpuri Superspeciality Hospital, New Delhi 110 058, India
2 Department of Pathology, Janakpuri Superspeciality Hospital, New Delhi 110 058, India

Date of Web Publication21-Apr-2015

Correspondence Address:
Man Mohan Mehndiratta
Department of Neurology, Janakpuri Superspeciality Hospital, New Delhi 110 058
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-5916.155531

Rights and Permissions

How to cite this article:
Mehndiratta MM, Wadhai SA. International Epilepsy Day - A day notified for global public education & awareness. Indian J Med Res 2015;141:143-4

How to cite this URL:
Mehndiratta MM, Wadhai SA. International Epilepsy Day - A day notified for global public education & awareness. Indian J Med Res [serial online] 2015 [cited 2019 Dec 9];141:143-4. Available from: http://www.ijmr.org.in/text.asp?2015/141/2/143/155531

Epilepsy is a common medical disorder that can have a psychological and emotional impact on people with this disorder and their caregivers. About 65 million people worldwide have epilepsy [1] and nearly 80 per cent of the people with epilepsy (PWE) live in developing countries, where annual new cases occur between 40 to 70 per 100,000 people in the general population. The estimated proportion of the general population with active epilepsy at a given time is between 4 to 10 per 1000 people. However, some of the studies from developing countries suggest that the proportion is between 6 to 10 per 1000 2 .

In the Global Burden of Disease Study 2010, of almost 14,000 people from a range of global settings, severe epilepsy was rated as having a disability adjusted life years (DALY) of 0.657 and total prevalent cases were 28,300,000 3 . Disease burden for epilepsy has been evaluated in economic terms by the European Brain Council for the European countries, with data from 2004 [4],[5] and 2010 [6] and based on epidemiological and health economic data it amounts to 161 and 212 million €, respectively.

It is estimated that there are more than 10 million PWE in India. In an earlier study their prevalence was about one per cent in our population [7] . The prevalence was higher in the rural population (1.9%) as compared with urban population (0.6%) [8],[9] . The overall prevalence of epilepsy in India has been estimated to be 5.59-10 per 1000 [7],[9],[10],[11] .

Almost 70 per cent of newly diagnosed children and adults with epilepsy can be successfully treated with anti-epileptic drugs (AEDs). Drugs can be withdrawn in about 70 per cent of children and 60 per cent of adults without relapses after two to five years of successful treatment. Approximately three-fourth of PWE in developing countries may not receive the treatment they need due to treatment gap of up to 80 per cent. In many low- and middle-income countries it is difficult to access treatment due to low availability and unaffordability of AEDs [2] .

Epilepsy is a cost intensive disorder. In a multicentric study on the cost of epilepsy in India, the total annual cost per people amounted to 13,755 (USD 344). The total economic burden of epilepsy in India was found to be 68.75 billion (1.72 billion USD) which constituted 0.5 per cent GNP of India [12] . There are global disparities in the care of people with epilepsy between high- and low-income countries and between rural and urban settings. However, more than 70 per cent of patients who are treated achieve long-term remission or freedom from seizures, usually within five years of diagnosis [13] .

The treatment gap is over 75 per cent in most low-income countries and over 50 per cent in many lower middle and upper middle income countries when compared with high income countries where it is less than 10 per cent. Furthermore, treatment gaps are twice as high in rural areas compared to urban areas [14] . In a systematic review the treatment gap in developing countries has been reported as low as 56 per cent [15] . The magnitude of epilepsy treatment gap in India is high and is influenced by lack of access to or knowledge of anti-epileptic drugs, poverty, cultural beliefs, stigma, poor health delivery infrastructure, shortage of trained professionals, inequitable distributions of available resources in rural areas and high cost of treatment [16],[17],[18] . Efforts need to be made to reduce the treatment gap in epilepsy. A substantial proportion of the current large treatment gap in epilepsy in the developing countries could be minimized by educating the primary care physicians about the diagnosis of epileptic seizures, cost-effective AED treatment, availability of specialist health professionals in low- and middle- income countries and need-based referral for specialized care [19] .

Epilepsy due to perinatal brain injury remains an important problem in developing countries and contributes significantly to the burden of epilepsy in the developing world. Predominant causes are perinatal asphyxia, neonatal hypoglycaemia, sepsis-meningitis, late haemorrhagic disease of the newborn and perinatal ischaemic arterial stroke, all of which are preventable [20] .

International Epilepsy Day is likely to improve public awareness and raise visibility of epilepsy globally which will ultimately lead to improved access to AEDs, provision of cost-effective treatment, improved funding for research activity in epilepsy and development of appropriate legislation to protect the rights of all people with epilepsy.

 
   References Top

1.
Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010; 51 : 883-90.  Back to cited text no. 1
    
2.
World Health Organization. Epilepsy Fact Sheet No. 999: key facts (2012). Available from: http://www.who.int/mediacentre/factsheets/fs999/en/, accessed on March 1, 2014.  Back to cited text no. 2
    
3.
Whiteford HA, Ferrari AJ, Degenhardt L, Feigin V, Vos T. The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. PLoS One 2015; 10 : e0116820.  Back to cited text no. 3
    
4.
Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12 (Suppl. 1): 1-27.   Back to cited text no. 4
    
5.
Stovner LJ, Gjerstad L, Gilhus NE, Storstein A, Zwart JA. Cost of disorders of the brain in Norway. Acta Neurol Scand 2010; 190 (Suppl.): 1-5.   Back to cited text no. 5
    
6.
Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al; for CDBE2010 Study Group. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21 : 718-79.   Back to cited text no. 6
    
7.
Sridharan R, Murthy BN. Prevalence and pattern of epilepsy in India. Epilepsia 1999; 40 : 631-6.  Back to cited text no. 7
    
8.
Pahl K, de Boer H. Epilepsy and rights. In: Atlas: epilepsy care in the world. Geneva: World Health Organization; 2005. p. 72-3.  Back to cited text no. 8
    
9.
Gourie-Devi M, Gururaj G, Satishchandra P, Subbakrishna DK. Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas. Neuroepidemiology 2004; 23 : 261-8.  Back to cited text no. 9
    
10.
Sridharan R. Epidemiology of epilepsy. Curr Sci 2002; 82 : 664-70.  Back to cited text no. 10
    
11.
Goel D, Agarwal A, Dhanai JS, Semval VD, Mehrotra V, Saxena V, et al. Comprehensive rural epilepsy surveillance programme in Uttarakhand state of India. Neurol India 2009; 57 : 355-6.  Back to cited text no. 11
[PUBMED]    
12.
Thomas SV, Sarma PS, Alexander M, Pandit L, Shekhar L, Trivedi C, et al. Economic burden of epilepsy in India. Epilepsia 2001; 42 : 1052-60.   Back to cited text no. 12
    
13.
de Boer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy Behav 2008; 12 : 540-6.  Back to cited text no. 13
    
14.
Meyer AC, Dua T, Ma J, Saxena S, Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010; 88 : 260-6.  Back to cited text no. 14
    
15.
Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008; 49 : 1491-503.  Back to cited text no. 15
    
16.
Meinardi H, Scott RA, Reis R, Sander JW. ILAE Commission on the Developing World. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001; 42 : 136-49.  Back to cited text no. 16
    
17.
Scott RA, Lhatoo SD, Sander JW. The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ 2001; 79 : 344-51.  Back to cited text no. 17
    
18.
Radhakrishnan K. Challenges in the management of epilepsy in resource-poor countries. Nat Rev Neurol 2009; 5 : 323-30.  Back to cited text no. 18
    
19.
Iyer RS, Rekha M, Kumar TS, Sarma PS, Radhakrishnan K. Primary care doctors′ management behavior with respect to epilepsy in Kerala, southern India. Epilepsy Behav 2011; 21 : 137-42.  Back to cited text no. 19
    
20.
Udani V. Epilepsies due to perinatal brain injuries: focus on prevention. Neurol Asia 2011; 16 (Suppl 1) : 17-9.  Back to cited text no. 20
    



This article has been cited by
1 Evaluation of sodium valproate loaded nanoparticles in acute and chronic pentylenetetrazole induced seizure models
Meenakshi Meenu,K.H. Reeta,Amit Kumar Dinda,Sarat Kumar Kottarath,Yogendra Kumar Gupta
Epilepsy Research. 2019; : 106219
[Pubmed] | [DOI]
2 Orphan G protein-coupled receptors: The role in CNS disorders
Mohaddeseh Sadat Alavi,Ali Shamsizadeh,Hassan Azhdari-Zarmehri,Ali Roohbakhsh
Biomedicine & Pharmacotherapy. 2018; 98: 222
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed608    
    Printed7    
    Emailed0    
    PDF Downloaded201    
    Comments [Add]    
    Cited by others 2    

Recommend this journal